You are on page 1of 60

Group=All groups combined

22:15 Thursday, May 31, 2012 1

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

6481269

0.2 (0.2, 0.2)

1.8 (1.8, 1.8)

0.34

1.06

0-5

553390

0.0 (0.0, 0.0)

5.5 (5.4, 5.6)

0.18

1.38

6-11

704009

2.2 (2.2, 2.3)

8.7 (8.6, 8.8)

0.18

1.25

12-23

1464870

0.0 (0.0, 0.0)

1.0 (1.0, 1.0)

0.41

0.97

24-35

1059399

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.53

1.08

36-47

1120644

0.0 (0.0, 0.0)

0.7 (0.7, 0.7)

0.15

0.96

48-60

1578956

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.41

0.92

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 2

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

6481269

0.5 (0.4, 0.5)

6.6 (6.6, 6.6)

-0.11

1.13

0-5

553390

0.0 (0.0, 0.0)

1.3 (1.3, 1.4)

0.10

1.43

6-11

704009

2.2 (2.2, 2.3)

10.2 (10.2, 10.3)

-0.27

1.31

12-23

1464870

0.4 (0.4, 0.4)

6.0 (6.0, 6.1)

-0.13

1.04

24-35

1059399

0.0 (0.0, 0.0)

3.5 (3.5, 3.6)

-0.12

0.96

36-47

1120644

0.7 (0.7, 0.7)

9.5 (9.5, 9.6)

-0.31

1.12

48-60

1578956

0.0 (0.0, 0.0)

7.3 (7.3, 7.4)

0.04

1.10

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 3

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

6481269

0.1 (0.1, 0.1)

0.6 (0.6, 0.6)

31.4 (31.4, 31.4)

7.6 (7.6, 7.6)

0.5 (0.5, 0.5)

0.57

0.96

0-5

553390

0.8 (0.8, 0.8)

0.8 (0.8, 0.8)

22.6 (22.5, 22.7)

3.4 (3.4, 3.5)

0.0 (0.0, 0.0)

0.19

1.05

6-11

704009

0.0 (0.0, 0.0)

3.4 (3.4, 3.4)

41.5 (41.4, 41.7)

4.0 (4.0, 4.0)

0.3 (0.3, 0.3)

0.53

1.13

12-23

1464870

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

29.4 (29.3, 29.4)

7.7 (7.6, 7.7)

0.5 (0.5, 0.5)

0.63

0.93

24-35

1059399

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

40.8 (40.7, 40.8)

20.6 (20.5, 20.7)

1.5 (1.4, 1.5)

0.82

1.10

36-47

1120644

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

27.0 (26.9, 27.1)

5.5 (5.4, 5.5)

0.0 (0.0, 0.0)

0.49

0.81

48-60

1578956

0.0 (0.0, 0.0)

0.6 (0.6, 0.6)

28.7 (28.6, 28.8)

3.5 (3.5, 3.5)

0.5 (0.5, 0.5)

0.55

0.80

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 4

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

6481269

0.1 (0.1, 0.1)

0.7 (0.7, 0.7)

31.9 (31.9, 32.0)

8.2 (8.2, 8.2)

0.5 (0.5, 0.5)

0.60

0.98

0-5

553390

0.8 (0.8, 0.8)

2.6 (2.5, 2.6)

23.8 (23.7, 23.9)

8.6 (8.5, 8.7)

0.0 (0.0, 0.0)

0.19

1.23

6-11

704009

0.0 (0.0, 0.0)

3.4 (3.4, 3.4)

30.4 (30.3, 30.5)

4.5 (4.5, 4.6)

0.0 (0.0, 0.0)

0.46

1.16

12-23

1464870

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

32.2 (32.1, 32.2)

8.2 (8.1, 8.2)

0.5 (0.5, 0.5)

0.69

0.92

24-35

1059399

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

42.2 (42.1, 42.2)

21.4 (21.3, 21.4)

1.5 (1.4, 1.5)

0.87

1.10

36-47

1120644

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

26.7 (26.6, 26.8)

5.5 (5.4, 5.5)

0.0 (0.0, 0.0)

0.51

0.80

48-60

1578956

0.0 (0.0, 0.0)

0.6 (0.6, 0.6)

32.1 (32.0, 32.2)

2.8 (2.8, 2.9)

0.5 (0.5, 0.5)

0.59

0.79

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 5

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

3382423

0.5 (0.5, 0.5)

2.5 (2.4, 2.5)

0.29

1.12

0-5

367732

0.0 (0.0, 0.0)

7.0 (7.0, 7.1)

0.19

1.52

6-11

318197

4.9 (4.8, 5.0)

13.3 (13.2, 13.5)

-0.14

1.39

12-23

776054

0.0 (0.0, 0.0)

1.9 (1.9, 1.9)

0.17

0.90

24-35

621927

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.39

1.04

36-47

695454

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.17

0.99

48-60

603058

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.77

0.95

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 6

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

3382423

0.6 (0.6, 0.7)

7.2 (7.2, 7.2)

-0.12

1.26

0-5

367732

0.0 (0.0, 0.0)

2.0 (1.9, 2.0)

0.03

1.58

6-11

318197

4.9 (4.8, 5.0)

16.7 (16.6, 16.8)

-0.68

1.49

12-23

776054

0.8 (0.8, 0.8)

5.6 (5.5, 5.6)

-0.13

1.05

24-35

621927

0.0 (0.0, 0.0)

6.0 (6.0, 6.1)

-0.23

1.02

36-47

695454

0.0 (0.0, 0.0)

9.9 (9.8, 9.9)

-0.32

1.24

48-60

603058

0.0 (0.0, 0.0)

5.6 (5.5, 5.7)

0.42

1.20

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 7

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

3382423

0.0 (0.0, 0.0)

1.0 (1.0, 1.0)

29.3 (29.2, 29.3)

5.9 (5.9, 5.9)

0.6 (0.6, 0.6)

0.50

0.96

0-5

367732

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

25.5 (25.4, 25.7)

3.3 (3.2, 3.3)

0.0 (0.0, 0.0)

0.24

1.02

6-11

318197

0.0 (0.0, 0.0)

7.5 (7.4, 7.6)

37.5 (37.3, 37.7)

4.5 (4.4, 4.6)

0.7 (0.6, 0.7)

0.38

1.22

12-23

776054

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

15.7 (15.6, 15.8)

3.6 (3.6, 3.7)

1.0 (1.0, 1.0)

0.32

0.82

24-35

621927

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

35.2 (35.1, 35.3)

14.0 (13.9, 14.1)

1.7 (1.6, 1.7)

0.73

1.08

36-47

695454

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

33.0 (32.9, 33.1)

3.0 (3.0, 3.1)

0.0 (0.0, 0.0)

0.54

0.77

48-60

603058

0.0 (0.0, 0.0)

1.5 (1.5, 1.6)

34.4 (34.2, 34.5)

6.2 (6.1, 6.2)

0.0 (0.0, 0.0)

0.69

0.93

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 8

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

3382423

0.0 (0.0, 0.0)

1.3 (1.3, 1.3)

30.1 (30.0, 30.1)

6.9 (6.9, 7.0)

0.5 (0.5, 0.5)

0.54

1.00

0-5

367732

0.0 (0.0, 0.0)

2.7 (2.6, 2.7)

27.6 (27.4, 27.7)

9.7 (9.6, 9.8)

0.0 (0.0, 0.0)

0.24

1.27

6-11

318197

0.0 (0.0, 0.0)

7.5 (7.4, 7.6)

28.3 (28.1, 28.4)

5.7 (5.6, 5.8)

0.0 (0.0, 0.0)

0.34

1.21

12-23

776054

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

14.1 (14.0, 14.2)

4.6 (4.5, 4.6)

1.0 (1.0, 1.0)

0.36

0.80

24-35

621927

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

36.5 (36.4, 36.6)

14.0 (13.9, 14.1)

1.7 (1.6, 1.7)

0.76

1.07

36-47

695454

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

33.0 (32.9, 33.1)

3.0 (3.0, 3.1)

0.0 (0.0, 0.0)

0.57

0.77

48-60

603058

0.0 (0.0, 0.0)

1.5 (1.5, 1.6)

43.1 (43.0, 43.2)

6.2 (6.1, 6.2)

0.0 (0.0, 0.0)

0.79

0.93

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 9

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

3098846

0.0 (0.0, 0.0)

1.0 (1.0, 1.0)

0.39

0.99

0-5

185658

0.0 (0.0, 0.0)

2.4 (2.4, 2.5)

0.17

1.05

6-11

385812

0.0 (0.0, 0.0)

4.9 (4.8, 5.0)

0.45

1.05

12-23

688816

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.68

0.97

24-35

437472

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.73

1.10

36-47

425190

0.0 (0.0, 0.0)

1.9 (1.9, 2.0)

0.10

0.90

48-60

975898

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.18

0.83

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 10

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

3098846

0.2 (0.2, 0.3)

5.9 (5.9, 5.9)

-0.11

0.97

0-5

185658

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.22

1.06

6-11

385812

0.0 (0.0, 0.0)

4.9 (4.8, 5.0)

0.07

1.02

12-23

688816

0.0 (0.0, 0.0)

6.5 (6.5, 6.6)

-0.13

1.03

24-35

437472

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.04

0.83

36-47

425190

1.8 (1.7, 1.8)

8.9 (8.8, 9.0)

-0.29

0.89

48-60

975898

0.0 (0.0, 0.0)

8.4 (8.3, 8.4)

-0.20

0.95

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 11

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

3098846

0.1 (0.1, 0.2)

0.1 (0.1, 0.2)

33.7 (33.6, 33.7)

9.5 (9.5, 9.5)

0.4 (0.4, 0.4)

0.64

0.95

0-5

185658

2.4 (2.4, 2.5)

2.4 (2.4, 2.5)

16.8 (16.6, 16.9)

3.7 (3.6, 3.8)

0.0 (0.0, 0.0)

0.09

1.11

6-11

385812

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

44.9 (44.7, 45.1)

3.6 (3.5, 3.6)

0.0 (0.0, 0.0)

0.65

1.04

12-23

688816

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

44.7 (44.6, 44.9)

12.2 (12.1, 12.3)

0.0 (0.0, 0.0)

0.99

0.93

24-35

437472

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

48.6 (48.5, 48.8)

29.9 (29.8, 30.1)

1.2 (1.2, 1.2)

0.95

1.12

36-47

425190

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

17.1 (17.0, 17.2)

9.4 (9.3, 9.5)

0.0 (0.0, 0.0)

0.41

0.86

48-60

975898

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

25.2 (25.1, 25.3)

1.9 (1.8, 1.9)

0.8 (0.8, 0.8)

0.46

0.70

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=All groups combined


22:15 Thursday, May 31, 2012 12

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

3098846

0.1 (0.1, 0.2)

0.1 (0.1, 0.2)

34.0 (33.9, 34.0)

9.6 (9.5, 9.6)

0.4 (0.4, 0.4)

0.66

0.96

0-5

185658

2.4 (2.4, 2.5)

2.4 (2.4, 2.5)

16.3 (16.2, 16.5)

6.3 (6.2, 6.4)

0.0 (0.0, 0.0)

0.08

1.12

6-11

385812

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

32.1 (32.0, 32.3)

3.6 (3.5, 3.6)

0.0 (0.0, 0.0)

0.56

1.10

12-23

688816

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

52.5 (52.4, 52.6)

12.2 (12.1, 12.3)

0.0 (0.0, 0.0)

1.06

0.90

24-35

437472

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

50.2 (50.0, 50.3)

31.8 (31.6, 31.9)

1.2 (1.2, 1.2)

1.01

1.12

36-47

425190

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

16.4 (16.3, 16.5)

9.4 (9.3, 9.5)

0.0 (0.0, 0.0)

0.40

0.84

48-60

975898

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

25.4 (25.3, 25.4)

0.8 (0.8, 0.8)

0.8 (0.8, 0.8)

0.47

0.67

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 13

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1851944

0.0 (0.0, 0.0)

3.3 (3.3, 3.3)

0.19

1.16

0-5

222636

0.0 (0.0, 0.0)

4.4 (4.3, 4.5)

0.10

1.59

6-11

236661

0.0 (0.0, 0.0)

18.1 (17.9, 18.2)

-0.19

1.27

12-23

458077

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.45

1.03

24-35

270981

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.04

0.97

36-47

276752

0.0 (0.0, 0.0)

2.9 (2.9, 3.0)

0.05

1.03

48-60

386837

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.43

1.02

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 14

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1851944

0.0 (0.0, 0.0)

12.7 (12.6, 12.7)

-0.30

1.22

0-5

222636

0.0 (0.0, 0.0)

3.3 (3.2, 3.4)

-0.15

1.52

6-11

236661

0.0 (0.0, 0.0)

9.7 (9.5, 9.8)

-0.50

1.13

12-23

458077

0.0 (0.0, 0.0)

12.0 (11.9, 12.1)

-0.19

1.20

24-35

270981

0.0 (0.0, 0.0)

13.8 (13.7, 14.0)

-0.52

1.03

36-47

276752

0.0 (0.0, 0.0)

11.0 (10.8, 11.1)

-0.57

0.95

48-60

386837

0.0 (0.0, 0.0)

21.1 (21.0, 21.2)

-0.06

1.29

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 15

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1851944

0.0 (0.0, 0.0)

1.3 (1.3, 1.3)

34.0 (34.0, 34.1)

5.3 (5.3, 5.4)

0.4 (0.4, 0.4)

0.51

0.95

0-5

222636

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.4 (30.2, 30.6)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.32

1.04

6-11

236661

0.0 (0.0, 0.0)

10.1 (10.0, 10.2)

25.0 (24.8, 25.1)

2.8 (2.7, 2.8)

0.0 (0.0, 0.0)

0.19

1.27

12-23

458077

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

33.3 (33.1, 33.4)

11.8 (11.7, 11.9)

1.7 (1.7, 1.7)

0.72

0.94

24-35

270981

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

24.8 (24.6, 24.9)

2.5 (2.5, 2.6)

0.0 (0.0, 0.0)

0.32

0.84

36-47

276752

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

33.7 (33.6, 33.9)

7.6 (7.5, 7.7)

0.0 (0.0, 0.0)

0.58

0.81

48-60

386837

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

49.3 (49.2, 49.5)

2.7 (2.6, 2.7)

0.0 (0.0, 0.0)

0.66

0.73

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 16

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1851944

0.0 (0.0, 0.0)

1.8 (1.8, 1.8)

32.5 (32.4, 32.5)

6.6 (6.6, 6.7)

0.4 (0.4, 0.4)

0.54

1.00

0-5

222636

0.0 (0.0, 0.0)

4.4 (4.3, 4.5)

26.2 (26.0, 26.4)

10.7 (10.5, 10.8)

0.0 (0.0, 0.0)

0.24

1.32

6-11

236661

0.0 (0.0, 0.0)

10.1 (10.0, 10.2)

25.0 (24.8, 25.1)

4.4 (4.3, 4.4)

0.0 (0.0, 0.0)

0.14

1.33

12-23

458077

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

28.9 (28.8, 29.0)

13.3 (13.2, 13.4)

1.7 (1.7, 1.7)

0.80

0.92

24-35

270981

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

24.8 (24.6, 24.9)

2.5 (2.5, 2.6)

0.0 (0.0, 0.0)

0.40

0.84

36-47

276752

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

33.7 (33.6, 33.9)

7.6 (7.5, 7.7)

0.0 (0.0, 0.0)

0.62

0.77

48-60

386837

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

49.3 (49.2, 49.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.70

0.67

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 17

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

975349

0.0 (0.0, 0.0)

3.5 (3.4, 3.5)

0.18

1.20

0-5

158647

0.0 (0.0, 0.0)

6.2 (6.0, 6.3)

0.11

1.80

6-11

108704

0.0 (0.0, 0.0)

22.0 (21.7, 22.2)

-0.62

1.20

12-23

230301

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.41

0.97

24-35

158709

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.29

1.01

36-47

172931

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.07

0.64

48-60

146056

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

1.15

0.43

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 18

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

975349

0.0 (0.0, 0.0)

6.6 (6.6, 6.7)

-0.17

1.28

0-5

158647

0.0 (0.0, 0.0)

4.6 (4.5, 4.7)

-0.33

1.62

6-11

108704

0.0 (0.0, 0.0)

3.7 (3.6, 3.8)

-0.72

1.03

12-23

230301

0.0 (0.0, 0.0)

6.8 (6.7, 6.9)

0.14

1.20

24-35

158709

0.0 (0.0, 0.0)

23.6 (23.4, 23.8)

-0.63

1.19

36-47

172931

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.64

0.70

48-60

146056

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.99

0.76

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 19

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

975349

0.0 (0.0, 0.0)

2.5 (2.4, 2.5)

29.9 (29.8, 30.0)

2.2 (2.1, 2.2)

0.8 (0.8, 0.8)

0.40

0.91

0-5

158647

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

40.5 (40.3, 40.8)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.49

1.04

6-11

108704

0.0 (0.0, 0.0)

22.0 (21.7, 22.2)

9.5 (9.3, 9.6)

6.0 (5.9, 6.2)

0.0 (0.0, 0.0)

-0.28

1.36

12-23

230301

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

23.5 (23.4, 23.7)

3.4 (3.3, 3.5)

3.4 (3.3, 3.5)

0.48

0.81

24-35

158709

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

8.5 (8.3, 8.6)

4.3 (4.2, 4.4)

0.0 (0.0, 0.0)

0.09

0.77

36-47

172931

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

37.3 (37.0, 37.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.67

0.44

48-60

146056

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

58.4 (58.2, 58.7)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.72

0.69

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 20

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

975349

0.0 (0.0, 0.0)

3.5 (3.4, 3.5)

26.9 (26.8, 27.0)

5.7 (5.7, 5.8)

0.8 (0.8, 0.8)

0.42

0.99

0-5

158647

0.0 (0.0, 0.0)

6.2 (6.0, 6.3)

34.7 (34.4, 34.9)

15.0 (14.8, 15.1)

0.0 (0.0, 0.0)

0.40

1.44

6-11

108704

0.0 (0.0, 0.0)

22.0 (21.7, 22.2)

9.5 (9.3, 9.6)

9.5 (9.3, 9.6)

0.0 (0.0, 0.0)

-0.29

1.40

12-23

230301

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

14.9 (14.7, 15.0)

6.5 (6.4, 6.6)

3.4 (3.3, 3.5)

0.47

0.79

24-35

158709

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

8.5 (8.3, 8.6)

4.3 (4.2, 4.4)

0.0 (0.0, 0.0)

0.16

0.74

36-47

172931

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

37.3 (37.0, 37.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.72

0.40

48-60

146056

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

58.4 (58.2, 58.7)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.82

0.63

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 21

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

876595

0.0 (0.0, 0.0)

3.1 (3.0, 3.1)

0.19

1.11

0-5

63989

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.05

0.84

6-11

127957

0.0 (0.0, 0.0)

14.7 (14.5, 14.9)

0.18

1.22

12-23

227776

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.49

1.09

24-35

112271

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.31

0.80

36-47

103821

0.0 (0.0, 0.0)

7.9 (7.7, 8.0)

0.00

1.47

48-60

240781

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.02

1.03

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 22

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

876595

0.0 (0.0, 0.0)

19.4 (19.3, 19.5)

-0.45

1.13

0-5

63989

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.30

1.09

6-11

127957

0.0 (0.0, 0.0)

14.7 (14.5, 14.9)

-0.31

1.18

12-23

227776

0.0 (0.0, 0.0)

17.3 (17.1, 17.4)

-0.53

1.11

24-35

112271

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.35

0.70

36-47

103821

0.0 (0.0, 0.0)

29.2 (28.9, 29.5)

-0.45

1.25

48-60

240781

0.0 (0.0, 0.0)

33.9 (33.7, 34.1)

-0.70

1.12

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 23

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

876595

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

38.6 (38.5, 38.7)

8.8 (8.8, 8.9)

0.0 (0.0, 0.0)

0.64

0.98

0-5

63989

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

5.3 (5.1, 5.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.09

0.91

6-11

127957

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

38.1 (37.9, 38.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.58

1.05

12-23

227776

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.1 (42.9, 43.3)

20.3 (20.1, 20.5)

0.0 (0.0, 0.0)

0.97

0.99

24-35

112271

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

47.8 (47.5, 48.1)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.65

0.82

36-47

103821

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

27.8 (27.6, 28.1)

20.2 (20.0, 20.5)

0.0 (0.0, 0.0)

0.42

1.19

48-60

240781

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.8 (43.6, 44.0)

4.3 (4.2, 4.4)

0.0 (0.0, 0.0)

0.63

0.75

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=East
22:15 Thursday, May 31, 2012 24

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

876595

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

38.6 (38.5, 38.7)

7.7 (7.6, 7.7)

0.0 (0.0, 0.0)

0.67

0.98

0-5

63989

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

5.3 (5.1, 5.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.16

0.81

6-11

127957

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

38.1 (37.9, 38.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.50

1.16

12-23

227776

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.1 (42.9, 43.3)

20.3 (20.1, 20.5)

0.0 (0.0, 0.0)

1.13

0.93

24-35

112271

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

47.8 (47.5, 48.1)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.73

0.85

36-47

103821

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

27.8 (27.6, 28.1)

20.2 (20.0, 20.5)

0.0 (0.0, 0.0)

0.45

1.13

48-60

240781

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.8 (43.6, 44.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.63

0.69

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 25

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1572224

0.0 (0.0, 0.0)

1.8 (1.7, 1.8)

0.36

1.03

0-5

89530

0.0 (0.0, 0.0)

18.0 (17.7, 18.2)

-0.47

1.30

6-11

127949

0.0 (0.0, 0.0)

2.3 (2.2, 2.4)

0.10

1.13

12-23

341883

0.0 (0.0, 0.0)

2.5 (2.5, 2.6)

0.18

0.90

24-35

252083

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.85

1.10

36-47

219409

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.09

0.91

48-60

541369

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.63

0.80

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 26

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1572224

0.0 (0.0, 0.0)

5.4 (5.3, 5.4)

-0.10

1.06

0-5

89530

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.60

1.36

6-11

127949

0.0 (0.0, 0.0)

5.4 (5.3, 5.6)

-0.40

1.14

12-23

341883

0.0 (0.0, 0.0)

2.5 (2.5, 2.6)

-0.23

0.84

24-35

252083

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.07

0.86

36-47

219409

0.0 (0.0, 0.0)

31.3 (31.1, 31.5)

-0.90

1.16

48-60

541369

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.38

0.87

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 27

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1572224

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.3 (30.3, 30.4)

10.4 (10.4, 10.5)

0.0 (0.0, 0.0)

0.58

0.97

0-5

89530

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

21.4 (21.2, 21.7)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.01

0.83

6-11

127949

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

36.7 (36.5, 37.0)

4.5 (4.4, 4.6)

0.0 (0.0, 0.0)

0.49

1.10

12-23

341883

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

28.6 (28.5, 28.8)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.39

0.99

24-35

252083

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

60.3 (60.1, 60.5)

31.9 (31.7, 32.1)

0.0 (0.0, 0.0)

1.12

1.06

36-47

219409

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

18.4 (18.2, 18.5)

18.4 (18.2, 18.5)

0.0 (0.0, 0.0)

0.66

0.82

48-60

541369

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

22.3 (22.2, 22.4)

6.9 (6.8, 6.9)

0.0 (0.0, 0.0)

0.55

0.85

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 28

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1572224

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

35.7 (35.6, 35.8)

10.7 (10.7, 10.8)

0.0 (0.0, 0.0)

0.62

1.00

0-5

89530

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

8.1 (7.9, 8.3)

5.5 (5.3, 5.6)

0.0 (0.0, 0.0)

-0.19

1.07

6-11

127949

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

36.7 (36.5, 37.0)

4.5 (4.4, 4.6)

0.0 (0.0, 0.0)

0.44

1.11

12-23

341883

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

44.3 (44.1, 44.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.45

1.01

24-35

252083

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

60.3 (60.1, 60.5)

31.9 (31.7, 32.1)

0.0 (0.0, 0.0)

1.17

1.03

36-47

219409

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

18.4 (18.2, 18.5)

18.4 (18.2, 18.5)

0.0 (0.0, 0.0)

0.74

0.80

48-60

541369

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.2 (30.1, 30.3)

6.9 (6.8, 6.9)

0.0 (0.0, 0.0)

0.59

0.86

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 29

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

728251

0.0 (0.0, 0.0)

3.8 (3.7, 3.8)

0.29

1.14

0-5

54933

0.0 (0.0, 0.0)

29.3 (28.9, 29.7)

-0.69

1.43

6-11

58664

0.0 (0.0, 0.0)

5.0 (4.8, 5.2)

0.31

1.11

12-23

166098

0.0 (0.0, 0.0)

5.2 (5.1, 5.3)

-0.24

0.75

24-35

105681

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.79

0.76

36-47

145383

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.43

0.82

48-60

197493

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

1.26

0.77

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 30

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

728251

0.0 (0.0, 0.0)

11.6 (11.5, 11.6)

-0.18

1.24

0-5

54933

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.55

1.57

6-11

58664

0.0 (0.0, 0.0)

11.8 (11.6, 12.1)

-0.73

0.96

12-23

166098

0.0 (0.0, 0.0)

5.2 (5.1, 5.3)

-0.17

0.86

24-35

105681

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.10

0.60

36-47

145383

0.0 (0.0, 0.0)

47.2 (46.9, 47.4)

-1.35

1.06

48-60

197493

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.88

0.89

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 31

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

728251

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

29.0 (28.9, 29.1)

9.7 (9.6, 9.8)

0.0 (0.0, 0.0)

0.57

1.02

0-5

54933

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

7.6 (7.3, 7.8)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.30

0.58

6-11

58664

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

69.5 (69.1, 69.9)

9.7 (9.5, 10.0)

0.0 (0.0, 0.0)

0.98

0.97

12-23

166098

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

7.9 (7.8, 8.1)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.20

0.80

24-35

105681

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

73.8 (73.5, 74.1)

6.1 (6.0, 6.2)

0.0 (0.0, 0.0)

1.17

0.81

36-47

145383

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

14.6 (14.4, 14.8)

14.6 (14.4, 14.8)

0.0 (0.0, 0.0)

0.56

0.69

48-60

197493

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

27.2 (27.0, 27.4)

18.8 (18.7, 19.0)

0.0 (0.0, 0.0)

1.01

1.04

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 32

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

728251

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

35.6 (35.5, 35.7)

9.7 (9.6, 9.8)

0.0 (0.0, 0.0)

0.61

1.06

0-5

54933

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.52

0.99

6-11

58664

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

69.5 (69.1, 69.9)

9.7 (9.5, 10.0)

0.0 (0.0, 0.0)

0.97

0.96

12-23

166098

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

7.9 (7.8, 8.1)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.17

0.80

24-35

105681

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

73.8 (73.5, 74.1)

6.1 (6.0, 6.2)

0.0 (0.0, 0.0)

1.20

0.79

36-47

145383

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

14.6 (14.4, 14.8)

14.6 (14.4, 14.8)

0.0 (0.0, 0.0)

0.69

0.68

48-60

197493

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

53.8 (53.6, 54.1)

18.8 (18.7, 19.0)

0.0 (0.0, 0.0)

1.11

1.02

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 33

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

843974

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.42

0.91

0-5

34597

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.13

0.97

6-11

69286

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.08

1.11

12-23

175786

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.59

0.85

24-35

146403

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.90

1.29

36-47

74027

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.57

0.67

48-60

343876

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.26

0.56

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 34

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

843974

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.03

0.88

0-5

34597

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.67

0.93

6-11

69286

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.13

1.20

12-23

175786

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.28

0.83

24-35

146403

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.19

0.99

36-47

74027

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.01

0.76

48-60

343876

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.09

0.71

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 35

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

843974

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

31.5 (31.4, 31.6)

11.0 (11.0, 11.1)

0.0 (0.0, 0.0)

0.60

0.94

0-5

34597

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.4 (42.9, 44.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.49

0.94

6-11

69286

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

9.0 (8.8, 9.2)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.08

1.03

12-23

175786

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

48.2 (48.0, 48.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.93

0.82

24-35

146403

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

50.5 (50.3, 50.8)

50.5 (50.3, 50.8)

0.0 (0.0, 0.0)

1.09

1.21

36-47

74027

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

25.8 (25.5, 26.1)

25.8 (25.5, 26.1)

0.0 (0.0, 0.0)

0.85

0.99

48-60

343876

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

19.5 (19.3, 19.6)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.28

0.58

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=North
22:15 Thursday, May 31, 2012 36

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

843974

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

35.8 (35.7, 35.9)

11.6 (11.5, 11.7)

0.0 (0.0, 0.0)

0.62

0.94

0-5

34597

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

21.0 (20.5, 21.4)

14.2 (13.8, 14.5)

0.0 (0.0, 0.0)

0.35

0.97

6-11

69286

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

9.0 (8.8, 9.2)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.00

1.04

12-23

175786

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

78.7 (78.5, 78.9)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

1.04

0.80

24-35

146403

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

50.5 (50.3, 50.8)

50.5 (50.3, 50.8)

0.0 (0.0, 0.0)

1.14

1.18

36-47

74027

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

25.8 (25.5, 26.1)

25.8 (25.5, 26.1)

0.0 (0.0, 0.0)

0.83

1.00

48-60

343876

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

16.6 (16.5, 16.8)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.30

0.56

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 37

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1245020

0.0 (0.0, 0.0)

0.5 (0.5, 0.5)

0.36

0.98

0-5

82581

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.62

0.97

6-11

131067

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.69

1.00

12-23

189467

0.0 (0.0, 0.0)

3.3 (3.2, 3.4)

0.35

1.11

24-35

329353

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.52

1.05

36-47

205784

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.11

0.59

48-60

306768

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.16

0.93

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 38

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1245020

0.5 (0.5, 0.5)

6.2 (6.1, 6.2)

-0.07

1.15

0-5

82581

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.75

1.10

6-11

131067

0.0 (0.0, 0.0)

14.3 (14.1, 14.5)

-0.02

1.44

12-23

189467

3.3 (3.2, 3.4)

12.9 (12.8, 13.1)

-0.12

1.35

24-35

329353

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.22

0.90

36-47

205784

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.16

0.38

48-60

306768

0.0 (0.0, 0.0)

11.0 (10.9, 11.1)

-0.28

1.32

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 39

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1245020

0.0 (0.0, 0.0)

0.7 (0.7, 0.8)

34.1 (34.0, 34.1)

7.6 (7.5, 7.6)

1.2 (1.2, 1.3)

0.56

1.04

0-5

82581

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

14.6 (14.4, 14.9)

14.6 (14.4, 14.9)

0.0 (0.0, 0.0)

0.13

1.28

6-11

131067

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

65.3 (65.0, 65.5)

5.0 (4.9, 5.1)

0.0 (0.0, 0.0)

1.06

0.78

12-23

189467

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

37.3 (37.0, 37.5)

4.4 (4.3, 4.5)

0.0 (0.0, 0.0)

0.57

0.92

24-35

329353

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

37.5 (37.3, 37.7)

20.5 (20.3, 20.6)

4.7 (4.6, 4.8)

0.88

1.20

36-47

205784

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

16.3 (16.1, 16.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.02

0.98

48-60

306768

0.0 (0.0, 0.0)

3.0 (3.0, 3.1)

32.2 (32.0, 32.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.48

0.73

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 40

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1245020

0.0 (0.0, 0.0)

0.7 (0.7, 0.8)

32.4 (32.3, 32.5)

8.2 (8.2, 8.3)

1.2 (1.2, 1.3)

0.59

1.05

0-5

82581

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

21.6 (21.4, 21.9)

14.6 (14.4, 14.9)

0.0 (0.0, 0.0)

0.28

1.23

6-11

131067

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

45.3 (45.1, 45.6)

5.0 (4.9, 5.1)

0.0 (0.0, 0.0)

0.97

0.82

12-23

189467

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

37.3 (37.0, 37.5)

4.4 (4.3, 4.5)

0.0 (0.0, 0.0)

0.63

0.86

24-35

329353

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

37.5 (37.3, 37.7)

22.9 (22.8, 23.1)

4.7 (4.6, 4.8)

0.94

1.21

36-47

205784

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

16.3 (16.1, 16.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.03

1.02

48-60

306768

0.0 (0.0, 0.0)

3.0 (3.0, 3.1)

32.2 (32.0, 32.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.55

0.75

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 41

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

727204

0.0 (0.0, 0.0)

0.9 (0.8, 0.9)

0.27

1.01

0-5

66645

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.67

0.92

6-11

64655

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.42

1.13

12-23

98544

0.0 (0.0, 0.0)

6.4 (6.2, 6.5)

0.08

1.13

24-35

235029

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.46

1.08

36-47

134431

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.19

0.66

48-60

127902

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.16

0.83

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 42

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

727204

0.9 (0.8, 0.9)

9.8 (9.7, 9.9)

-0.24

1.21

0-5

66645

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.79

1.15

6-11

64655

0.0 (0.0, 0.0)

29.1 (28.7, 29.4)

-0.60

1.77

12-23

98544

6.4 (6.2, 6.5)

19.1 (18.9, 19.4)

-0.53

1.19

24-35

235029

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.29

0.97

36-47

134431

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.25

0.27

48-60

127902

0.0 (0.0, 0.0)

26.4 (26.2, 26.7)

-0.83

1.39

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 43

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

727204

0.0 (0.0, 0.0)

1.3 (1.3, 1.3)

36.1 (36.0, 36.2)

10.5 (10.4, 10.5)

1.4 (1.4, 1.4)

0.56

1.15

0-5

66645

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

18.1 (17.8, 18.4)

18.1 (17.8, 18.4)

0.0 (0.0, 0.0)

0.13

1.37

6-11

64655

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

80.4 (80.1, 80.7)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

1.17

0.32

12-23

98544

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.2 (29.9, 30.5)

8.4 (8.3, 8.6)

0.0 (0.0, 0.0)

0.47

0.94

24-35

235029

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

38.6 (38.4, 38.8)

23.7 (23.5, 23.9)

4.4 (4.3, 4.5)

0.87

1.23

36-47

134431

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

24.9 (24.6, 25.1)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.07

1.15

48-60

127902

0.0 (0.0, 0.0)

7.3 (7.2, 7.4)

34.6 (34.3, 34.9)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.50

0.92

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 44

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

727204

0.0 (0.0, 0.0)

1.3 (1.3, 1.3)

33.0 (32.9, 33.1)

10.5 (10.4, 10.5)

1.4 (1.4, 1.4)

0.61

1.15

0-5

66645

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

23.7 (23.3, 24.0)

18.1 (17.8, 18.4)

0.0 (0.0, 0.0)

0.32

1.29

6-11

64655

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

40.0 (39.7, 40.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

1.06

0.37

12-23

98544

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.2 (29.9, 30.5)

8.4 (8.3, 8.6)

0.0 (0.0, 0.0)

0.59

0.88

24-35

235029

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

38.6 (38.4, 38.8)

23.7 (23.5, 23.9)

4.4 (4.3, 4.5)

0.92

1.23

36-47

134431

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

24.9 (24.6, 25.1)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.00

1.20

48-60

127902

0.0 (0.0, 0.0)

7.3 (7.2, 7.4)

34.6 (34.3, 34.9)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.60

0.97

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 45

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

517816

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.50

0.93

0-5

15937

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.44

1.16

6-11

66412

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.96

0.76

12-23

90923

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.65

1.01

24-35

94324

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.67

0.95

36-47

71354

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.04

0.38

48-60

178867

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.39

0.93

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 46

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

517816

0.0 (0.0, 0.0)

1.1 (1.1, 1.1)

0.18

0.99

0-5

15937

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.61

0.89

6-11

66412

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.55

0.61

12-23

90923

0.0 (0.0, 0.0)

6.2 (6.0, 6.4)

0.33

1.36

24-35

94324

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.05

0.68

36-47

71354

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.00

0.50

48-60

178867

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.11

1.11

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 47

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

517816

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

31.2 (31.1, 31.3)

3.5 (3.5, 3.6)

1.0 (1.0, 1.0)

0.56

0.88

0-5

15937

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.12

0.83

6-11

66412

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

50.5 (50.1, 50.9)

9.9 (9.7, 10.1)

0.0 (0.0, 0.0)

0.95

1.03

12-23

90923

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

44.9 (44.5, 45.2)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.68

0.87

24-35

94324

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

34.8 (34.5, 35.1)

12.5 (12.3, 12.7)

5.5 (5.4, 5.7)

0.90

1.13

36-47

71354

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.07

0.51

48-60

178867

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.5 (30.3, 30.7)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.47

0.56

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=South
22:15 Thursday, May 31, 2012 48

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

517816

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

31.6 (31.5, 31.7)

5.1 (5.0, 5.1)

1.0 (1.0, 1.0)

0.58

0.89

0-5

15937

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

13.2 (12.7, 13.7)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.15

0.95

6-11

66412

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

50.5 (50.1, 50.9)

9.9 (9.7, 10.1)

0.0 (0.0, 0.0)

0.88

1.09

12-23

90923

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

44.9 (44.5, 45.2)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.67

0.85

24-35

94324

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

34.8 (34.5, 35.1)

20.9 (20.7, 21.2)

5.5 (5.4, 5.7)

0.98

1.14

36-47

71354

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.10

0.51

48-60

178867

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.5 (30.3, 30.7)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.52

0.55

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 49

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1812080

0.9 (0.8, 0.9)

1.1 (1.1, 1.1)

0.46

1.01

0-5

158643

0.0 (0.0, 0.0)

2.9 (2.8, 2.9)

0.45

1.12

6-11

208332

7.5 (7.4, 7.6)

7.5 (7.4, 7.6)

0.34

1.30

12-23

475443

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.55

0.85

24-35

206983

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.91

0.87

36-47

418698

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.35

1.03

48-60

343982

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.26

0.88

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 50

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

1812080

1.3 (1.3, 1.3)

1.7 (1.7, 1.7)

0.03

1.06

0-5

158643

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.49

1.23

6-11

208332

7.5 (7.4, 7.6)

11.2 (11.1, 11.4)

-0.08

1.43

12-23

475443

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.01

0.82

24-35

206983

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.33

0.79

36-47

418698

1.8 (1.8, 1.9)

1.8 (1.8, 1.9)

-0.05

1.25

48-60

343982

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.12

0.79

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 51

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1812080

0.3 (0.2, 0.3)

0.3 (0.2, 0.3)

27.8 (27.7, 27.9)

7.6 (7.5, 7.6)

0.5 (0.5, 0.6)

0.62

0.89

0-5

158643

2.9 (2.8, 2.9)

2.9 (2.8, 2.9)

16.4 (16.2, 16.6)

4.3 (4.2, 4.4)

0.0 (0.0, 0.0)

0.13

1.03

6-11

208332

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

48.4 (48.2, 48.6)

4.5 (4.4, 4.5)

1.0 (1.0, 1.0)

0.60

1.03

12-23

475443

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

23.0 (22.9, 23.1)

10.5 (10.5, 10.6)

0.0 (0.0, 0.0)

0.75

0.86

24-35

206983

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.0 (42.8, 43.2)

30.7 (30.5, 30.9)

0.0 (0.0, 0.0)

1.02

1.05

36-47

418698

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

32.3 (32.2, 32.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.57

0.59

48-60

343982

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

12.5 (12.4, 12.7)

2.2 (2.2, 2.3)

2.2 (2.2, 2.3)

0.48

0.84

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 52

An example survey
Restricted analysis (see Readme.pdf for its definition)
Sexes combined, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

1812080

0.3 (0.2, 0.3)

0.3 (0.2, 0.3)

27.8 (27.7, 27.9)

7.6 (7.5, 7.6)

0.4 (0.4, 0.4)

0.64

0.89

0-5

158643

2.9 (2.8, 2.9)

2.9 (2.8, 2.9)

30.5 (30.2, 30.7)

4.3 (4.2, 4.4)

0.0 (0.0, 0.0)

0.28

1.13

6-11

208332

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

23.2 (23.0, 23.4)

4.5 (4.4, 4.5)

0.0 (0.0, 0.0)

0.53

1.02

12-23

475443

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

24.5 (24.4, 24.6)

10.5 (10.5, 10.6)

0.0 (0.0, 0.0)

0.79

0.83

24-35

206983

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

50.2 (50.0, 50.4)

30.7 (30.5, 30.9)

0.0 (0.0, 0.0)

1.01

1.10

36-47

418698

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

31.6 (31.5, 31.8)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.58

0.55

48-60

343982

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

15.7 (15.6, 15.9)

2.2 (2.2, 2.3)

2.2 (2.2, 2.3)

0.49

0.83

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 53

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

951619

1.6 (1.6, 1.7)

1.6 (1.6, 1.7)

0.42

1.07

0-5

87508

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.52

1.08

6-11

86175

18.1 (17.8, 18.4)

18.1 (17.8, 18.4)

-0.25

1.67

12-23

281112

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.24

0.73

24-35

122509

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.79

0.71

36-47

242709

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.60

1.20

48-60

131607

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.50

0.96

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 54

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

951619

1.6 (1.6, 1.7)

2.5 (2.4, 2.5)

0.07

1.28

0-5

87508

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.48

1.46

6-11

86175

18.1 (17.8, 18.4)

27.2 (26.9, 27.5)

-0.63

1.96

12-23

281112

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.18

0.90

24-35

122509

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.30

0.90

36-47

242709

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.22

1.46

48-60

131607

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.32

0.85

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 55

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

951619

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

23.7 (23.6, 23.8)

3.4 (3.4, 3.5)

0.2 (0.2, 0.2)

0.52

0.79

0-5

87508

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

15.2 (15.0, 15.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.20

0.71

6-11

86175

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

18.8 (18.5, 19.1)

2.4 (2.3, 2.5)

2.4 (2.3, 2.5)

0.22

1.08

12-23

281112

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

8.8 (8.7, 8.9)

4.3 (4.2, 4.4)

0.0 (0.0, 0.0)

0.45

0.64

24-35

122509

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

30.0 (29.8, 30.3)

14.9 (14.7, 15.1)

0.0 (0.0, 0.0)

0.92

0.93

36-47

242709

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

45.6 (45.4, 45.8)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.70

0.61

48-60

131607

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

18.2 (18.0, 18.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.37

0.84

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 56

An example survey
Restricted analysis (see Readme.pdf for its definition)
Males, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

951619

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

26.8 (26.7, 26.9)

3.4 (3.4, 3.5)

0.0 (0.0, 0.0)

0.56

0.79

0-5

87508

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

35.1 (34.8, 35.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.40

0.84

6-11

86175

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

15.1 (14.9, 15.3)

2.4 (2.3, 2.5)

0.0 (0.0, 0.0)

0.18

1.04

12-23

281112

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

11.4 (11.3, 11.5)

4.3 (4.2, 4.4)

0.0 (0.0, 0.0)

0.51

0.62

24-35

122509

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

36.6 (36.3, 36.9)

14.9 (14.7, 15.1)

0.0 (0.0, 0.0)

0.87

0.98

36-47

242709

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

45.6 (45.4, 45.8)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.72

0.55

48-60

131607

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

18.2 (18.0, 18.4)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.46

0.86

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 57

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

860461

0.0 (0.0, 0.0)

0.5 (0.5, 0.5)

0.50

0.92

0-5

71135

0.0 (0.0, 0.0)

6.4 (6.2, 6.6)

0.36

1.17

6-11

122157

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.75

0.69

12-23

194332

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

1.01

0.82

24-35

84474

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

1.08

1.05

36-47

175988

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.01

0.59

48-60

212375

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.12

0.79

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 58

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, LENGTH/HEIGHT-FOR-AGE
AGE GROUPS (Months)

Prevalence (95% CI)

N
Total

<-3 SD

z-scores

<-2 SD

Mean

SD

860461

0.9 (0.9, 0.9)

0.9 (0.9, 0.9)

-0.01

0.76

0-5

71135

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.49

0.87

6-11

122157

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.31

0.66

12-23

194332

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.25

0.60

24-35

84474

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.37

0.58

36-47

175988

4.3 (4.2, 4.4)

4.3 (4.2, 4.4)

-0.43

0.74

48-60

212375

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

-0.39

0.59

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 59

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, WEIGHT-FOR-LENGTH/HEIGHT
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

860461

0.5 (0.5, 0.5)

0.5 (0.5, 0.5)

32.3 (32.2, 32.4)

12.2 (12.1, 12.3)

0.9 (0.9, 0.9)

0.73

0.98

0-5

71135

6.4 (6.2, 6.6)

6.4 (6.2, 6.6)

17.9 (17.6, 18.2)

9.6 (9.4, 9.8)

0.0 (0.0, 0.0)

0.04

1.33

6-11

122157

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

69.3 (69.1, 69.6)

5.9 (5.8, 6.0)

0.0 (0.0, 0.0)

0.87

0.90

12-23

194332

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.5 (43.3, 43.7)

19.5 (19.4, 19.7)

0.0 (0.0, 0.0)

1.20

0.93

24-35

84474

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

61.9 (61.5, 62.2)

53.6 (53.2, 53.9)

0.0 (0.0, 0.0)

1.16

1.19

36-47

175988

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

13.9 (13.8, 14.1)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.40

0.51

48-60

212375

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

9.0 (8.9, 9.2)

3.6 (3.6, 3.7)

3.6 (3.6, 3.7)

0.54

0.83

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

Group=West
22:15 Thursday, May 31, 2012 60

An example survey
Restricted analysis (see Readme.pdf for its definition)
Females, BMI-FOR-AGE run
AGE GROUPS
(Months)

Prevalence (95% CI)

N
Total

<-3 SD

<-2 SD

>+1 SD

z-scores

>+2 SD

>+3 SD

Mean

SD

860461

0.5 (0.5, 0.5)

0.5 (0.5, 0.5)

28.9 (28.8, 29.0)

12.2 (12.1, 12.3)

0.9 (0.9, 0.9)

0.72

0.98

0-5

71135

6.4 (6.2, 6.6)

6.4 (6.2, 6.6)

24.8 (24.5, 25.1)

9.6 (9.4, 9.8)

0.0 (0.0, 0.0)

0.15

1.39

6-11

122157

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

28.9 (28.7, 29.2)

5.9 (5.8, 6.0)

0.0 (0.0, 0.0)

0.77

0.92

12-23

194332

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

43.5 (43.3, 43.7)

19.5 (19.4, 19.7)

0.0 (0.0, 0.0)

1.20

0.92

24-35

84474

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

69.9 (69.6, 70.2)

53.6 (53.2, 53.9)

0.0 (0.0, 0.0)

1.21

1.21

36-47

175988

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

12.4 (12.2, 12.5)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.40

0.51

48-60

212375

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

14.2 (14.1, 14.4)

3.6 (3.6, 3.7)

3.6 (3.6, 3.7)

0.51

0.80

0-60

There are no subjects with missing age. Number of subjects with oedema: 56170
Subjects with either missing age or oedema are excluded from this analysis.

You might also like